Krystal Biotech Inc Long-term Investment Intensity

Latest as of June 2026: 17.1%

Krystal Biotech Inc long-term investment intensity. Krystal Biotech Inc (KRYS) has a Long-term Investment Intensity of 17.1% as of June 2026. Long-term investments of $257.29 Million represent 17.1% of total assets of $1.50 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read how much debt does Krystal Biotech Inc carry for a breakdown of total debt and financial obligations.

LT Investment Intensity

17.1%
LT Investments / Total Assets

Long-term Investments

$257.29 Million
USD

Total Assets

$1.50 Billion
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Krystal Biotech Inc (2019–2025)

Long-term investment intensity of Krystal Biotech Inc from 2019 to 2025. This chart shows how Krystal Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2025. As of June 2026, the intensity stands at 17.1%, reflecting long-term investments of $257.29 Million against total assets of $1.50 Billion USD.

Krystal Biotech Inc Long-term Investment Intensity by Year (2019–2025)

Krystal Biotech Inc long-term investment intensity by year from 2019 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Krystal Biotech Inc from 2019 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Krystal Biotech Inc assets under control.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 9.6% $128.07 Million $1.33 Billion ▼ -4.8 pp
2024 14.4% $152.11 Million $1.06 Billion ▲ +6.8 pp
2023 7.6% $61.95 Million $818.36 Million ▲ +6.7 pp
2022 0.8% $4.62 Million $558.45 Million ▼ -9.5 pp
2021 10.3% $64.37 Million $626.29 Million ▲ +10.0 pp
2019 0.2% $497.00K $209.02 Million —
pp = percentage points